Search

everythinglearnresearchcommunity

for

Search:↓

Hidradenitis Suppurativa is likely an autoinflammatory disease, and better understanding its causes could improve treatments.

In 2017, pediatric dermatology advanced with new treatments and insights into various skin conditions in children.

Treatment with biologic agents can significantly improve psoriasis symptoms, and blood biomarkers could potentially predict individual patient's response to treatment.

Adalimumab can cause complete hair loss in rare cases.

The issue concluded that various skin conditions have different effective treatments and factors influencing them.

Real-life dosing of biologics for plaque psoriasis often deviates from recommended guidelines, especially for high-need patients.

Biologic agents can be effective for rheumatic diseases but have risks like infections and require careful monitoring and patient information.

A multi-tiered treatment approach is crucial for managing hidradenitis suppurativa in patients with intellectual and developmental disabilities.

A multi-tiered treatment approach is crucial for managing hidradenitis suppurativa in patients with intellectual and developmental disorders.

The study found that immune responses disrupt hair growth cycles, causing hair loss in alopecia areata.

IMSG nanoparticles improve vaccine delivery and immune response through hair follicles.

The document concludes that ongoing research using animal models is crucial for better understanding and treating Alopecia Areata.

Alopecia areata involves immune response and gene changes affecting hair loss.

Men are more likely to have severe respiratory viral infections like COVID-19 due to hormonal and genetic differences, while women generally have stronger immune responses.

TH antibodies in vitiligo and AA patients recognize the same protein parts.

People on immune-modifying skin disease treatments may have a weaker antibody response to COVID-19 vaccines but often improve after the second dose.

The complement system might be involved in the development of alopecia areata and could lead to new treatments.

Skin pigmentation increases in CRPS-affected areas and improves with symptom relief.

Unani medicine and modern dermatology both offer treatments for ichthyosis, a condition causing dry, scaly skin.

Avicenna's work greatly shaped modern dermatology.

The study concluded that there is no significant link between thyroid autoimmunity and alopecia areata.

Booster shots of mRNA vaccines for COVID-19 increased protective antibodies without worsening autoimmune skin conditions in patients.

Trichohyalin in hair can trigger immune attacks in alopecia areata.

Infliximab successfully treated a severe hair loss case in Sri Lanka.

Rats can develop an immune response to prion protein peptides, but it may cause severe skin issues in older rats.

Unani medicine offers a natural, effective approach to treating hair loss with minimal side effects, but needs more scientific validation.

A woman's hair grew back within 3 months after temporary hair loss from improper head positioning during shoulder surgery.

Targeting abnormal lung fluid metabolism could reduce COVID-19 deaths and ventilator use.

This method is effective for needle-free HIV-1 vaccination by activating immune responses in the skin.

Tocilizumab therapy may cause skin and hair conditions like halo naevi, vitiligo, and alopecia areata.